Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Nattokinase {Natto} - Parvibacter |
👶
Lactobacillus casei Zhang and vitamin K2 prevent intestinal tumorigenesis in mice via adiponectin-elevated different signaling pathways. Oncotarget (Oncotarget ) Vol: 8 Issue 15 Pages: 24719-24727 Pub: 2017 Apr 11 Epub: Authors Zhang Y , Ma C , Zhao J , Xu H , Hou Q , Zhang H , Html Article Publication |
| Nattokinase {Natto} - Parvibacter |
👶
Supplementation with Natto and Red Yeast Rice Alters Gene Expressions in Cholesterol Metabolism Pathways in ApoE(-/-) Mice with Concurrent Changes in Gut Microbiota. Nutrients (Nutrients ) Vol: 15 Issue 4 Pages: Pub: 2023 Feb 15 Epub: 2023 Feb 15 Authors Zhou H , Liu W , Lv Y , Liu K , Wang Y , Meng S , Kang T , Bao Y , Meng H , Html Article Publication |
| Nattokinase {Natto} - Parvibacter |
📓
Effects of Bacillus subtilis natto JLCC513 on gut microbiota and intestinal barrier function in obese rats. Journal of applied microbiology (J Appl Microbiol ) Vol: 133 Issue 6 Pages: 3634-3644 Pub: 2022 Dec Epub: 2022 Sep 14 Authors Sun R , Niu H , Sun M , Miao X , Jin X , Xu X , Yanping C , Mei H , Wang J , Da L , Su Y , Publication |
| Nattokinase {Natto} - Parvibacter |
📓
Modulatory Effect of Fermented Black Soybean and Adlay on Gut Microbiota Contributes to Healthy Aging. Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 67 Issue 5 Pages: e2200700 Pub: 2023 Mar Epub: 2023 Feb 2 Authors Koh YC , Kuo LH , Chang YY , Tung YC , Lo YC , Pan MH , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
